At a glance
ClinicalIndex Comparison RecordN/ACompleted· 70 enrolled
Drug / intervention
AVIVO™ PiiX Patch Monitor Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Observational Study of Reducing 30-day Admissions in Post-discharge Subjects
In Brief
An observational study evaluating AVIVO™ PiiX Patch Monitor System for Acute Decompensated Heart Failure. Completed, enrolled 70 participants across 8 sites in 2 countries.
Detailed Summary
The purpose of this observational study is to collect and characterize multiple physiologic data from a broad subset of subjects with acute heart failure (HF) Changes in physiologic data are expected to correlate with 30-day readmission rates in this population
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Decompensated Heart Failure
CountriesAustralia, United States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2012
First PostedApr 2012
Primary CompletionApr 2013
Study CompletionAug 2013
TodayJul 2026
First PostedApr 10, 2012
Enrollment StartApr 1, 2012
Primary CompletionApr 1, 2013
Study CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 14.2 years ago
Interventions
AVIVO™ PiiX Patch Monitor Systemdevice
External monitoring for 30 days post-discharge.